SWITCH THERAPEUTICS

In News

Stoke Therapeutics Auditor Switch Puts Biotech Governance In Focus - Yahoo Finance

Yahoo Finance - Apr 06, 2026

Leading with resilience: Dee Datta’s journey from Caltech Labs to biotech entrepreneurship - The Business Journals

The Business Journals - Sep 09, 2025

Dual switches ignite tumour-specific mRNA therapeutics - Nature

Nature - Nov 12, 2025

Gene therapy ‘switch’ may offer non-addictive pain relief - Penn Medicine

Penn Medicine - Jan 07, 2026

Turn Therapeutics Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Nasdaq - Oct 08, 2025

Turn Therapeutics Launches First Clinical Trial to Assess Topical IL-36 Inhibitor for Atopic Dermatitis - Patient Care Online

Patient Care Online - Jul 15, 2025

Turn Therapeutics Pushes Eczema Therapy Into Clinical Trials - Dermatology Times

Dermatology Times - Aug 26, 2025

Molecular Switch Targeting Therapies Market Landscape, Innovation Pipeline and Commercial Impact Research Report 2026 - ResearchAndMarkets.com - Business Wire

Business Wire - Jan 30, 2026

Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today? - Stocktwits

Stocktwits - Oct 09, 2025

Integrating ON-OFF switches for targeted mRNA therapeutics - Phys.org

Phys.org - Jul 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

CNN - Oct 08, 2025

Switch Therapeutics Launches to Develop Targeted siRNA Therapies - Inside Precision Medicine

Inside Precision Medicine - Mar 14, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment